SKK
TVRD

Shepherd Kaplan Krochuk’s Tvardi Therapeutics TVRD Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-877
Closed -$391K – 259
2018
Q1 		$391K Buy
877
+142
+19% +$68.9K 0.24% 122
2017
Q4 		$324K Sell
735
-735
-50% -$335K 0.2% 135
2017
Q3 		$725K Hold
1,470
– – 0.6% 52
2017
Q2 		$815K Hold
1,470
– – 0.48% 54
2017
Q1 		$974K Sell
1,470
-957
-39% -$511K 0.5% 45
2016
Q4 		$812K Sell
2,427
-2,064
-46% -$662K 0.23% 55
2016
Q3 		$1.35M Sell
4,491
-758
-14% -$164K 0.28% 47
2016
Q2 		$909K Buy
5,249
+1,309
+33% +$285K 0.23% 66
2016
Q1 		$882K Buy
3,940
+2,177
+123% +$650K 0.27% 59
2015
Q4 		$1.07M Sell
1,763
-1,421
-45% -$780K 0.28% 56
2015
Q3 		$1.64M Sell
3,184
-590
-16% -$395K 0.44% 28
2015
Q2 		$1.65M Hold
3,774
– – 0.31% 54
2015
Q1 		$1.37M Buy
3,774
+724
+24% +$274K 0.24% 73
2014
Q4 		$1.09M Sell
3,050
-128
-4% -$41.2K 0.18% 119
2014
Q3 		$960K Buy
3,178
+1,521
+92% +$625K 0.12% 140
2014
Q2 		$1.01M Buy
1,657
+179
+12% +$96.4K 0.11% 139
2014
Q1 		$990K Buy
+1,478
New +$874K 0.11% 146

Other funds holding TVRD

RCP
Rho Capital Partners New York $20.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shepherd Kaplan Krochuk's TVRD Position: Q2 2018 in Review

Shepherd Kaplan Krochuk sold out of Tvardi Therapeutics (TVRD) in Q2 2018, closing a stake of 877 shares — an estimated $391K sold.

Shepherd Kaplan Krochuk first reported a position in TVRD in Q1 2014 and held it in 17 quarters. The position peaked at $1.65M in Q2 2015. 130 funds tracked by Wall St. Rank hold TVRD as of Q2 2018.

  • Shepherd Kaplan Krochuk reported no remaining Tvardi Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 877 Tvardi Therapeutics shares in Q2 2018, an estimated $391K.
  • Shepherd Kaplan Krochuk first reported a position in Tvardi Therapeutics in Q1 2014 and held it in 17 quarters.
  • Shepherd Kaplan Krochuk's Tvardi Therapeutics position peaked at $1.65M in Q2 2015.
  • 130 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2018, filed 14 Aug 2018.